Debbie Rigby rounds up the latest in research news Does coprescribing nonsteroidal anti-inflammatory drugs and oral anticoagulants increase the risk of major bleeding, stroke and systemic embolism? When OACs are coprescribed with NSAIDs, the risk of adverse bleeding events increases and, simultaneously, the protective effect of OACs to prevent strokes reduces. Compared with OAC therapy
This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.